Who Buys Nivolumab from India — 47 Importers Behind a $2.3M Market
India's nivolumab import market is served by 47 active buyers who collectively imported $2.3M across 144 shipments. ALMAC PHARMACEUTICAL SERVICES PTE LIMITED (SINGAPORE) leads with a 46.0% market share, followed by COREX LLC and AS PER INVOICE. The top 5 buyers together control 85.9% of total import value, reflecting a concentrated buyer landscape.
Top Nivolumab Importers — Ranked by Import Value
ALMAC PHARMACEUTICAL SERVICES PTE LIMITED (SINGAPORE) is the leading nivolumab importer from India, holding a 46.0% share of the $2.3M market across 144 shipments from 47 buyers. The top 5 buyers — ALMAC PHARMACEUTICAL SERVICES PTE LIMITED (SINGAPORE), COREX LLC (RUSSIA), AS PER INVOICE (BRAZIL), STATE TRADING ORGANIZATION PLC (MALDIVES), JAIR CARLOS DE ARAUJO (BRAZIL) — collectively control 85.9% of total import value.
Top Nivolumab Buyers & Importers
Ranked by import value · 47 active buyers · Indian Customs (DGFT) data
| # | Buyer & Formulations | Value | Suppliers | Share |
|---|---|---|---|---|
| 1 | ALMAC PHARMACEUTICAL SERVICES PTE LIMITEDSINGAPORE NIVOLUMAB AEX IP,NIVOLUMAB PALS ,NIVOLUMAB UF OP, | $1.1M | 5 | 46.0% |
| 2 | COREX LLCRUSSIA NIVOLUMAB 100MG/10ML-FOR TESTING PURPOSEONLYNIVOLUMAB 100MG 10ML FOR TESTING PURPOSEONLYNIVOLUMAB 40MG/4ML-FOR TESTING PURPOSE ONLY | $773.4K | 5 | 33.9% |
| 3 | AS PER INVOICEBRAZIL HARMLESS MEDICINE FOR HUMAN CONSUMPTIONNIVOLUMAB 100MGOPDIVO 100MG INJECTION EACH TABLET CONTAINS NIVOLUMABOPDYTA 100MG NIVOLUMAB CONCENTRATE FORSO | $72.9K | 5 | 3.2% |
| 4 | STATE TRADING ORGANIZATION PLCMALDIVES OPDYTA 40 MG INJ NIVOLUMABOPDYTA 100MG INJ NIVOLUMABNIVOLUMAB - INJECTIONS - 100MG - OPDYTA | $32.3K | 5 | 1.4% |
| 5 | JAIR CARLOS DE ARAUJOBRAZIL HARMLESS MEDICINE FOR HUMAN CONSUMPTIONNIVOLUMAB 100MGOPDIVO 100MG INJECTION EACH TABLET CONTAINS NIVOLUMAB | $30.5K | 5 | 1.3% |
| 6 | HEALTH CARE AGENCYSEYCHELLES NIVOLUMAB 100MG/10 MLVLSOPDYTA 100 MG NIVOLUMAB 100 MGOPDYTA 40 MG NIVOLUMAB 40 MG | $21.7K | 5 | 1.0% |
| 7 | INDIRA GANDHI MEMORIAL HOSPITALMALDIVES OPDYTA 40 MG INJ NIVOLUMABOPDYTA 100MG INJ NIVOLUMABNIVOLUMAB - INJECTIONS - 100MG - OPDYTA | $12.0K | 5 | 0.5% |
| 8 | FRANCISCO EUDES DA SILVABRAZIL HARMLESS MEDICINE FOR HUMAN CONSUMPTIONNIVOLUMAB 100MGOPDIVO 100MG INJECTION EACH TABLET CONTAINS NIVOLUMAB | $11.8K | 5 | 0.5% |
| 9 | ELIZETE DE OLIVEIRA DA SILVABRAZIL HARMLESS MEDICINE FOR HUMAN CONSUMPTIONNIVOLUMAB 100MGOPDIVO 100MG INJECTION EACH TABLET CONTAINS NIVOLUMAB | $11.8K | 5 | 0.5% |
| 10 | INVOICE RAISED TO SEYCHELLESSEYCHELLES HARMLESS MEDICINE FOR HUMAN CONSUMPTIONNIVOLUMAB 100MGOPDYTA 100 MG NIVOLUMAB 100 MGOPDYTA 40 MG INJ NIVOLUMAB | $11.8K | 5 | 0.5% |
| 11 | RINEA IVETE ROOS BOERBRAZIL HARMLESS MEDICINE FOR HUMAN CONSUMPTIONNIVOLUMAB 100MGOPDIVO 100MG INJECTION EACH TABLET CONTAINS NIVOLUMAB | $11.2K | 5 | 0.5% |
| 12 | SHYSLAYNY MARIA CUNHA DE LIRABRAZIL HARMLESS MEDICINE FOR HUMAN CONSUMPTIONNIVOLUMAB 100MGOPDIVO 100MG INJECTION EACH TABLET CONTAINS NIVOLUMAB | $8.9K | 5 | 0.4% |
| 13 | SEBASTIAO HORMINDO CARIOLANDOBRAZIL HARMLESS MEDICINE FOR HUMAN CONSUMPTIONNIVOLUMAB 100MGOPDIVO 100MG INJECTION EACH TABLET CONTAINS NIVOLUMAB | $8.9K | 5 | 0.4% |
Related Analysis
Market Analysis: Top Importing Countries & Importers
Comprehensive geographic market intelligence dashboard
Which companies are buying Nivolumab — and from which countries?
Flow of Nivolumab exports from India: each country's share and the named importers behind the numbers
Nivolumab — Buyer Countries to Key Importers
Trade flow: top importing countries → named buyer companies
Market Analysis: Top Importing Countries & Their Importers
1Singapore
Singapore emerges as the first largest importing country, achieving a total trade value of $1.1M through 2 shipments. This represents a market share of 46.0% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Singapore has a diverse importer base, with their top importers including:
• ALMAC PHARMACEUTICAL SERVICES PTE LIMITED - $1.1M (100.0% of country's total business)
Key Insight: Singapore demonstrates strong market positioning with an average shipment value of $525.6K, indicating premium pricing strategy compared to the market average of $15.9K.
Singapore is a key market for Nivolumab imports, representing 46.0% of total trade value.
2Russia
Russia emerges as the second largest importing country, achieving a total trade value of $773.4K through 8 shipments. This represents a market share of 33.9% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Russia has a diverse importer base, with their top importers including:
• COREX LLC - $773.4K (100.0% of country's total business)
Key Insight: Russia demonstrates strong market positioning with an average shipment value of $96.7K, indicating premium pricing strategy compared to the market average of $15.9K.
Russia is a key market for Nivolumab imports, representing 33.9% of total trade value.
3Brazil
Brazil emerges as the third largest importing country, achieving a total trade value of $280.5K through 23 shipments. This represents a market share of 12.3% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Brazil has a diverse importer base, with their top importers including:
• AS PER INVOICE - $72.9K (26.0% of country's total business)
• JAIR CARLOS DE ARAUJO - $30.5K (10.9% of country's total business)
• FRANCISCO EUDES DA SILVA - $11.8K (4.2% of country's total business)
• ELIZETE DE OLIVEIRA DA SILVA - $11.8K (4.2% of country's total business)
• RINEA IVETE ROOS BOER - $11.2K (4.0% of country's total business)
• Rest of Brazil's importers - $142.3K (50.7% of country's total business)
Key Insight: Brazil demonstrates strong market positioning with an average shipment value of $12.2K, indicating competitive pricing strategy compared to the market average of $15.9K.
Brazil is a key market for Nivolumab imports, representing 12.3% of total trade value.
4Seychelles
Seychelles emerges as the fourth largest importing country, achieving a total trade value of $56.6K through 4 shipments. This represents a market share of 2.5% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Seychelles has a diverse importer base, with their top importers including:
• HEALTH CARE AGENCY - $21.7K (38.4% of country's total business)
• INVOICE RAISED TO SEYCHELLES - $11.8K (20.8% of country's total business)
Key Insight: Seychelles demonstrates strong market positioning with an average shipment value of $14.2K, indicating competitive pricing strategy compared to the market average of $15.9K.
Seychelles is a key market for Nivolumab imports, representing 2.5% of total trade value.
5Maldives
Maldives emerges as the fifth largest importing country, achieving a total trade value of $54.8K through 11 shipments. This represents a market share of 2.4% of the total market activity, demonstrating their significant presence in the industry.
Top Importers: Maldives has a diverse importer base, with their top importers including:
• STATE TRADING ORGANIZATION PLC - $32.3K (58.9% of country's total business)
• INDIRA GANDHI MEMORIAL HOSPITAL - $12.0K (22.0% of country's total business)
Key Insight: Maldives demonstrates strong market positioning with an average shipment value of $5.0K, indicating competitive pricing strategy compared to the market average of $15.9K.
Maldives is a key market for Nivolumab imports, representing 2.4% of total trade value.
Buyer Segment Analysis
TransData Nexus Nivolumab buyer market intelligence
1Buyer Segment Analysis
The importers of Nivolumab from India can be categorized into several key segments:
1. Distributors: Entities like ALMAC PHARMACEUTICAL SERVICES PTE LIMITED in Singapore and COREX LLC in Russia function as intermediaries, procuring Nivolumab in bulk and supplying it to healthcare providers within their respective regions. Their purchasing patterns typically involve large-volume orders to meet the demands of multiple clients.
2. Hospital Groups: Institutions such as INDIRA GANDHI MEMORIAL HOSPITAL in the Maldives directly import Nivolumab to administer to patients within their facilities. Their procurement is often based on patient needs and treatment schedules, leading to periodic, demand-driven orders.
3. Government Procurement Agencies: Organizations like the STATE TRADING ORGANIZATION PLC in the Maldives and HEALTH CARE AGENCY in Seychelles are responsible for national healthcare procurement. They often engage in tender-based purchasing, aiming to secure medications at competitive prices for public health initiatives.
4. Individual Buyers: Entities listed as "AS PER INVOICE" in Brazil and individuals like JAIR CARLOS DE ARAUJO and FRANCISCO EUDES DA SILVA represent personal imports, possibly for specific patient treatments. Their purchasing behavior is typically characterized by smaller, one-time orders.
Understanding these segments is crucial for tailoring market strategies, as each exhibits distinct procurement behaviors and order patterns.
Country-Specific Import Regulations
TransData Nexus Nivolumab buyer market intelligence
1Country-Specific Import Regulations
For the top five importing countries, the import regulations for Nivolumab are as follows:
1. Singapore:
2. Russia:
3. Brazil:
4. Seychelles:
5. Maldives:
These regulatory frameworks and tariffs significantly influence the importation process and market entry strategies for Nivolumab in these countries.
Demand Drivers & Market Opportunity
TransData Nexus Nivolumab buyer market intelligence
1Demand Drivers & Market Opportunity
The demand for Nivolumab in importing countries is driven by several factors:
1. Disease Prevalence: Nivolumab is primarily used in the treatment of various cancers, including melanoma, non-small cell lung cancer, and renal cell carcinoma. The prevalence of these cancers in countries like Singapore, Russia, and Brazil contributes to the consistent demand for this immunotherapy.
2. Government Healthcare Programs: Many importing countries have national healthcare programs that subsidize or fully cover the cost of essential medicines, including cancer treatments. For instance, Brazil's Unified Health System (SUS) provides access to oncology medications, influencing procurement patterns.
3. Universal Health Coverage Expansion: Efforts to expand universal health coverage in countries like the Maldives and Seychelles have led to increased access to advanced therapies, thereby boosting demand for drugs like Nivolumab.
4. WHO Essential Medicines List Procurement: While Nivolumab is not currently listed on the WHO Essential Medicines List, its inclusion in national formularies and treatment guidelines can drive procurement through public health channels.
5. Tender-Based Purchasing: Government and hospital tenders are common procurement methods, especially in countries with centralized healthcare systems. These tenders often result in bulk purchasing agreements, influencing the volume and frequency of Nivolumab imports.
With 47 buyers across 13 countries, the market for Nivolumab imported from India reflects a diverse and expanding landscape, shaped by healthcare policies, disease burden, and procurement practices.
Common Questions — Nivolumab Buyers & Importers
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
QWho is the largest nivolumab buyer importing from India?
Based on import volume and value, ALMAC PHARMACEUTICAL SERVICES PTE LIMITED (SINGAPORE) leads with $1.1M in imports and a 46.0% market share — the highest of any single nivolumab importer. COREX LLC (RUSSIA) and AS PER INVOICE (BRAZIL) are the next largest buyers.
QHow many companies buy nivolumab from India?
There are 47 active nivolumab buyers importing from India, with a combined market of $2.3M across 144 shipments to 13 countries. The top 5 buyers hold 85.9% of total import value, while the remaining 42 buyers handle the other 14.1%.
QWhich countries import the most nivolumab from India?
The top importing countries for nivolumab from India are Singapore (46.0%), Russia (33.9%), Brazil (12.3%), Seychelles (2.5%), Maldives (2.4%). These markets represent the largest demand centres for Indian pharmaceutical exports of nivolumab, with buyers ranging from government procurement agencies to private pharmaceutical distributors.
QWhat is the average import order value for nivolumab from India?
The average import transaction value for nivolumab from India is $15.9K, with an average unit price of $583.34 per unit. Order sizes vary significantly based on buyer type — government tenders tend to be larger while private distributors place more frequent smaller orders.
Buyer Segment Analysis
TransData Nexus Nivolumab buyer market intelligence
1Buyer Segment Analysis
The importers of Nivolumab from India can be categorized into several key segments:
1. Distributors: Entities like ALMAC PHARMACEUTICAL SERVICES PTE LIMITED in Singapore and COREX LLC in Russia function as intermediaries, procuring Nivolumab in bulk and supplying it to healthcare providers within their respective regions. Their purchasing patterns typically involve large-volume orders to meet the demands of multiple clients.
2. Hospital Groups: Institutions such as INDIRA GANDHI MEMORIAL HOSPITAL in the Maldives directly import Nivolumab to administer to patients within their facilities. Their procurement is often based on patient needs and treatment schedules, leading to periodic, demand-driven orders.
3. Government Procurement Agencies: Organizations like the STATE TRADING ORGANIZATION PLC in the Maldives and HEALTH CARE AGENCY in Seychelles are responsible for national healthcare procurement. They often engage in tender-based purchasing, aiming to secure medications at competitive prices for public health initiatives.
4. Individual Buyers: Entities listed as "AS PER INVOICE" in Brazil and individuals like JAIR CARLOS DE ARAUJO and FRANCISCO EUDES DA SILVA represent personal imports, possibly for specific patient treatments. Their purchasing behavior is typically characterized by smaller, one-time orders.
Understanding these segments is crucial for tailoring market strategies, as each exhibits distinct procurement behaviors and order patterns.
Country-Specific Import Regulations
TransData Nexus Nivolumab buyer market intelligence
1Country-Specific Import Regulations
For the top five importing countries, the import regulations for Nivolumab are as follows:
1. Singapore:
2. Russia:
3. Brazil:
4. Seychelles:
5. Maldives:
These regulatory frameworks and tariffs significantly influence the importation process and market entry strategies for Nivolumab in these countries.
Demand Drivers & Market Opportunity
TransData Nexus Nivolumab buyer market intelligence
1Demand Drivers & Market Opportunity
The demand for Nivolumab in importing countries is driven by several factors:
1. Disease Prevalence: Nivolumab is primarily used in the treatment of various cancers, including melanoma, non-small cell lung cancer, and renal cell carcinoma. The prevalence of these cancers in countries like Singapore, Russia, and Brazil contributes to the consistent demand for this immunotherapy.
2. Government Healthcare Programs: Many importing countries have national healthcare programs that subsidize or fully cover the cost of essential medicines, including cancer treatments. For instance, Brazil's Unified Health System (SUS) provides access to oncology medications, influencing procurement patterns.
3. Universal Health Coverage Expansion: Efforts to expand universal health coverage in countries like the Maldives and Seychelles have led to increased access to advanced therapies, thereby boosting demand for drugs like Nivolumab.
4. WHO Essential Medicines List Procurement: While Nivolumab is not currently listed on the WHO Essential Medicines List, its inclusion in national formularies and treatment guidelines can drive procurement through public health channels.
5. Tender-Based Purchasing: Government and hospital tenders are common procurement methods, especially in countries with centralized healthcare systems. These tenders often result in bulk purchasing agreements, influencing the volume and frequency of Nivolumab imports.
With 47 buyers across 13 countries, the market for Nivolumab imported from India reflects a diverse and expanding landscape, shaped by healthcare policies, disease burden, and procurement practices.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Buyer Identification: 47 global importers of Nivolumab identified from consignee fields in DGFT shipping bill records.
- 2.Import Value Analysis: Total import value aggregated from 144 individual shipping bill records. Values are FOB in USD.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation.
- 4.Geographic Distribution: Buyer imports distributed across 13 destination countries with market share per buyer calculated from capped values.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
144 Verified Shipments
47 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists